[27, 66, 78] Advances in the understanding of the underlying mechanisms involved in the relationships between high FOXC1 expression and increased HCC metastatic potential may yield effective targets for precise medical treatment for not only HCC, but other cancers as well. The gene discussed is FOXC1; the disease is hepatocellular carcinoma.